NAZIRA LTD
Company number 13552532 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
NAZIRA LTD - Analysis Report
Company Number: 13552532
Analysis Date: 2025-07-20 14:07 UTC
Credit Opinion: CONDITIONAL APPROVAL
Nazira Ltd is a very small, single-director private limited company operating in the healthcare sector (other human health activities). The company shows positive net current assets and net equity, but these are very modest (£338 net assets in 2024, up from £198 in 2023). The company’s cash position has improved slightly but remains low (£2,592). Given the scale and limited financial buffer, the company can likely meet short-term obligations but has limited resilience to adverse events or increased borrowing. Credit approval is recommended on a conditional basis, with small credit limits and close ongoing monitoring due to the low asset base and thin working capital.Financial Strength:
- Net assets and shareholder funds increased slightly from £198 in 2023 to £338 in 2024, showing minimal but positive retained earnings growth.
- Current liabilities almost doubled from £1,136 to £2,254, indicating some increased short-term obligations.
- Cash increased from £1,334 to £2,592, which partially offsets the rise in current liabilities but overall net current assets remain marginal (£338).
- The company has no fixed assets reported, indicating minimal long-term investment or collateral.
- The capital structure is simple: one director owning 100% of shares and voting rights, which suggests tight control but limited external capital.
- Cash Flow Assessment:
- Cash balances are low but positive and have improved year-on-year.
- Net current assets remain positive but very low, indicating limited working capital cushion.
- The increase in current liabilities from £1,136 to £2,254 requires scrutiny to ensure these are not short-term pressures that could strain liquidity.
- The company employs only one person (the director), so payroll and overheads are likely minimal, reducing cash burn risk.
- No detailed cash flow statement is provided, so assumptions on operating cash flow quality cannot be fully assessed.
- Monitoring Points:
- Watch for timely settlement of increasing current liabilities, especially "other creditors" which rose significantly (£364 to £2,064).
- Monitor cash flow closely to ensure liquidity remains positive.
- Track profitability and retained earnings growth since current equity levels are minimal.
- Observe any changes in director ownership or credit exposure.
- Review future filings for any sign of increased borrowing or delayed payment patterns.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.